Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery

被引：47

作者：

Andreasen J.J. ^{[1
,2
,7
]}

Riis A. ^{[3
]}

Hjortdal V.E. ^{[4
]}

Jørgensen J. ^{[5
]}

Sørensen H.T. ^{[2
,3
,6
]}

Johnsen S.P. ^{[2
,3
]}

机构：

[1] Department of Cardiothoracic Surgery, Aalborg Hospital, Aarhus University Hospital, Aalborg

[2] Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg

[3] Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus

[4] Department of Cardiothoracic and Vascular Surgery, Skejby Hospital, Aarhus University Hospital, Aarhus

[5] Department of Clinical Immunology, Skejby Hospital, Aarhus University Hospital, Aarhus

[6] Department of Epidemiology, Boston University School of Public Health, Boston, MA

[7] Department of Cardiothoracic Surgery, Aalborg Hospital, Aarhus University Hospital, DK-9100 Aalborg, Hobrovej

来源：

American Journal of Cardiovascular Drugs | 2006年 / 6卷 / 4期

关键词：

Coronary Artery Bypass Grafting; Current User; Transfusion Requirement; Allogeneic Blood Transfusion; Coronary Artery Bypass Grafting Patient;

D O I：

10.2165/00129784-200606040-00004

中图分类号：

学科分类号：

摘要：

Background: Selective serotonin reuptake inhibitors (SSRIs) inhibit platelet function, and use of these drugs has been associated with bleeding events. The objective of this study was to examine whether the requirement for red blood cell transfusion was increased following preoperative use of SSRIs among patients undergoing coronary artery bypass grafting (CABG). Methods: A population-based cohort study of transfusion requirements (red blood cells, fresh frozen plasma, and/or platelets) was conducted among patients undergoing CABG at either Aalborg or Skejby Hospitals between 1 January 1998 and 31 December 2003. All prescriptions for antidepressants, including SSRIs, filled before the date of admission for CABG were identified using prescription databases. Patients were categorized according to use of antidepressants (never users, current users [<90 days before admission for CABG], and former users). Antidepressants were classified according to their action on serotonin and norepinephrine reuptake mechanisms. Relative risk (RR) for transfusion were adjusted for: age; sex; preoperative use of platelet inhibitors (low-dose aspirin [acetylsalicylic acid], clopidogrel, and dipyridamole), NSAIDs and oral anticoagulants; place of surgery; extracorporeal circulation; concomitant valve surgery; and Charlson comorbidity index score. Results: There were 124 (3.5%) current users of SSRIs among 3454 patients. Adjusted RRs for transfusion among current users of SSRIs, users of nonselective serotonin reuptake inhibitor antidepressants, and users of other antidepressants were 1.1 (95% CI 0.9, 1.3), 0.9 (95% CI 0.6, 1.3), and 1.0 (95% CI 0.7, 1.5), respectively, when compared with never users of any type of antidepressant. The adjusted RR among former SSRI users was 1.0 (95% CI 0.7, 1.4). Risk of re-exploration for bleeding and mortality within 30 days did not differ according to the examined drug-exposure categories. Conclusion: Preoperative use of SSRIs was not associated with any substantially increased requirement for allogeneic red blood cell transfusion among patients undergoing CABG. The main strengths of this study are its relatively large size, the use of prospectively collected data obtained from population-based databases with complete follow-up, and the ability to examine specific types of antidepressants. The limitations include a lack of detailed clinical data regarding other factors that may influence transfusion requirements. © 2006 Adis Data Information BV. All rights reserved.

引用

页码：243 / 250

页数：7

共 27 条

[1] Spiess B.D., Transfusion of blood products affects outcome in cardiac surgery, Semin Cardiothorac Vasc Anesth, 8, pp. 267-281, (2004)
[2] Engoren M.C., Habib R.H., Zacharias A., Et al., Effect of blood transfusion on long-term survival after cardiac operation, Ann Thorac Surg, 74, pp. 1180-1186, (2002)
[3] Magovern J.A., Sakert T., Benckart D.H., Et al., A model for predicting transfusion after coronary artery bypass grafting, Ann Thorac Surg, 61, pp. 27-32, (1996)
[4] Serebruany V.L., Gurbel P.A., O'Connor C.M., Platelet inhibition by sertraline and n-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors, Pharmacol Res, 43, pp. 453-461, (2001)
[5] Hergovich N., Aigner M., Eichler H.-G., Et al., Paroxetine decreases platelet serotonin storage and platelet dysfunction in human beings, Clin Pharmacol Ther, 68, pp. 435-442, (2000)
[6] Dalton S.O., Johansen C., Mellemkjaer L., Et al., Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study, Arch Intern Med, 163, pp. 59-64, (2003)
[7] Van Walraven V., Mamdani M.M., Wells P.S., Et al., Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study, BMJ, 323, pp. 655-658, (2001)
[8] Meijer W.E.E., Heerdink E.R., Nolen W.A., Et al., Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants, Arch Intern Med, 164, pp. 2367-2370, (2004)
[9] Movig K.L.L., Janssen W.H.E., De Malefijt J., Et al., Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients, Arch Intern Med, 163, pp. 2354-2358, (2003)
[10] Ford D.E., Mead L.A., Chang P.P., Et al., Depression is a risk factor for coronary artery disease in men, Arch Intern Med, 158, pp. 1422-1426, (1998)

← 1 2 3 →